Peptide YY and Peptide YY Agonists for Treatment of Metabolic Disorders

a metabolic disorder and agonist technology, applied in the field of peptide yy and peptide yy agonists for the treatment of metabolic disorders, can solve the problems of reducing life span, carries a serious risk of co-morbidities, and obesity and its associated disorders are common and serious public health problems, so as to reduce nutrient availability and modulate nutrient availability
US20130023466A1Inactive Publication Date: 2013-01-24ASTRAZENECA PHARMA LP
1 Cites 1 Cited by

Patent Information

Authority / Receiving Office
US · United States
Patent Type
Applications(United States)
Current Assignee / Owner
ASTRAZENECA PHARMA LP
Publication Date
2013-01-24
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

Methods and compositions are disclosed to treat metabolic disorders such as obesity, diabetes, and increased cardiovascular risk comprising administering a therapeutically effective amount of a PYY or a PYY agonist.
Need to check novelty before this filing date? Find Prior Art

Description

CROSS-REFERENCE TO RELATED APPLICATION

[0001] This application is a continuation of and claims priority to pending U.S. patent application Ser. No. 10 / 016,969, entitled “Peptide YY and Peptide YY Agonists for Treatment of Metabolic Disorders,” filed Dec. 14, 2001, and claims priority to U.S. Provisional Application Ser. No. 60 / 256,216 entitled “Peptide YY and Peptide YY Agonists for Treatment of Obesity, Diabetes, and other Metabolic Disorders,” filed Dec. 15, 2000, each of which are hereby incorporated by reference in their entirety.FIELD OF THE INVENTION

[0002] The present invention relates to methods and compositions for treating metabolic conditions or disorders, particularly those which can be alleviated by reducing caloric availability, for example diabetes, obesity, eating disorders, insulin-resistance syndrome (Syndrome X), glucose intolerance, dyslipidemia, and cardiovascular disorders.BACKGROUND

[0003] A number of related hormones make up the pancreatic polypeptide (PP) family. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More